These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28198768)

  • 1. Long-term Follow-up of Humoral Immune Status in Adult Lung Transplant Recipients.
    van Kessel DA; Hoffman TW; Kwakkel-van Erp JM; Oudijk ED; Zanen P; Rijkers GT; Grutters JC
    Transplantation; 2017 Oct; 101(10):2477-2483. PubMed ID: 28198768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune status assessment in adult lung transplant candidates.
    van Kessel DA; Hoffman TW; van Velzen-Blad H; van de Graaf EA; Grutters JC; Rijkers GT
    Transpl Immunol; 2017 Feb; 40():31-34. PubMed ID: 27867073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness.
    Moberley S; Licciardi PV; Balloch A; Andrews R; Leach AJ; Kirkwood M; Binks P; Mulholland K; Carapetis J; Tang MLK; Skull S
    Vaccine; 2017 May; 35(22):2908-2915. PubMed ID: 28455171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes.
    Boelsen LK; Dunne EM; Lamb KE; Bright K; Cheung YB; Tikoduadua L; Russell FM; Mulholland EK; Licciardi PV; Satzke C
    Vaccine; 2015 Oct; 33(42):5708-5714. PubMed ID: 26232540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.
    Giebink GS; Warkentin PI; Ramsay NK; Kersey JH
    J Infect Dis; 1986 Oct; 154(4):590-6. PubMed ID: 3528315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
    Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP
    Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation.
    Sarmiento E; Rodríguez-Hernández C; Rodríguez-Molina J; Fernández-Yánez J; Palomo J; Anguita J; Pérez JL; Lanio N; Fernández-Cruz E; Carbone J
    Int Immunopharmacol; 2006 Dec; 6(13-14):2027-30. PubMed ID: 17161358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against Streptococcus pneumoniae in solid organ transplant recipients].
    Fiorante S; López-Medrano F; Ruiz-Contreras J; Aguado JM
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):589-92. PubMed ID: 19361892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation.
    Meerveld-Eggink A; van der Velden AM; Ossenkoppele GJ; van de Loosdrecht AA; Biesma DH; Rijkers GT
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1523-30. PubMed ID: 19896075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
    Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.
    Linnemann CC; First MR; Schiffman G
    Arch Intern Med; 1986 Aug; 146(8):1554-6. PubMed ID: 3524494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
    Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
    HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation.
    Dengler TJ; Strnad N; Bühring I; Zimmermann R; Girgsdies O; Kubler WE; Zielen S
    Transplantation; 1998 Nov; 66(10):1340-7. PubMed ID: 9846520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.
    Pasiarski M; Rolinski J; Grywalska E; Stelmach-Goldys A; Korona-Glowniak I; Gozdz S; Hus I; Malm A
    PLoS One; 2014; 9(12):e114966. PubMed ID: 25506837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.
    Dendle C; Stuart RL; Polkinghorne KR; Balloch A; Kanellis J; Ling J; Kummrow M; Moore C; Thursky K; Buttery J; Mulholland K; Gan PY; Holdsworth S; Mulley WR
    Transpl Infect Dis; 2018 Apr; 20(2):e12866. PubMed ID: 29512234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation.
    Cordonnier C; Labopin M; Chesnel V; Ribaud P; De La Camara R; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Einsele H; Niederwieser D; Apperley J; Ljungman P;
    Clin Infect Dis; 2009 May; 48(10):1392-401. PubMed ID: 19368505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial.
    Cordonnier C; Labopin M; Chesnel V; Ribaud P; Camara Rde L; Martino R; Ullmann AJ; Parkkali T; Locasciulli A; Yakouben K; Pauksens K; Bonnet E; Einsele H; Niederwieser D; Apperley J; Ljungman P
    Vaccine; 2010 Mar; 28(15):2730-4. PubMed ID: 20117269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older.
    Frenck RW; Fiquet A; Gurtman A; van Cleeff M; Davis M; Rubino J; Smith W; Sundaraiyer V; Sidhu M; Emini EA; Gruber WC; Scott DA; Schmoele-Thoma B;
    Vaccine; 2016 Jun; 34(30):3454-62. PubMed ID: 27155493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccination in lung transplant patients.
    Holzer L; Hoffman T; Van Kessel DA; Rijkers GT
    Expert Rev Vaccines; 2020 Mar; 19(3):227-234. PubMed ID: 32133883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.